Ondas (ONDS) Stock Drops 6% Despite 629% Revenue Surge and Massive Backlog Growth

The core disconnect is stark. Ondas reported fourth-quarter revenue of $30.1 million, a 629% year-over-year surge that met the high end of its raised guidance. Yet, the stock fell nearly 6% on March 6, driven by a $1.7 billion trading day and new defense contract announcements. This price action highlights a market focused on the path to profitability, not just the top-line explosion.

The profitability gap is wide. Despite the revenue leap, the company reported a net loss of $101.0 million for Q4. Even on an adjusted basis, the EBITDA loss is expanding, signaling that the massive growth is not yet translating into operational efficiency. This loss profile is the primary friction against a bullish price move, as investors weigh the backlog momentum against the cash burn.

The setup is one of high-stakes scaling. The company's year-end backlog jumped to $68.3 million, and its 2026 revenue projection is now a minimum of $375 million. The market is pricing in the risk that this growth ramp will require significant capital and time to become profitable, making the stock vulnerable to any perceived stumble in the execution of that plan.

The Backlog and Capital Fuel: $68.3M Pipeline, $960M Raised

The company's pipeline is now a major asset. Year-end backlog exploded to $68.3 million, more than tripling from the previous quarter's $20.3 million. This provides a substantial revenue cushion, with the entire 2026 guidance of at least $375 million representing just 5.5x the current backlog. The market is looking past the immediate cash burn to see if this order book can be converted into profitable sales.

Financial capacity is not the constraint. The balance sheet is robust, with approximately $594.4 million in cash as of year-end. More critically, the company raised approximately $960 million in net cash proceeds in January. This capital, combined with the existing cash, gives Ondas a pro forma cash position near $1.5 billion. This war chest funds both organic scaling and strategic M&A, removing a key execution risk.

The raised guidance sets a steep path. Management has doubled its full-year forecast to a minimum of $375 million, with Q1 2026 revenue projected at $38-40 million. This guidance, which significantly exceeds analyst estimates, is the direct result of the expanded backlog and the new capital. The flow of money is now aligned with the growth plan, but the stock's drop shows investors are still pricing in the execution risk of hitting these targets.

The Path to Profitability and Catalysts

The company must now translate massive revenue into profit. The Q4 2025 results show the stark gap: while revenue hit $30.1 million, adjusted EBITDA was a loss of -$9.9 million to -$9.4 million. The net income surge is driven by a ~$102 million warrant liability gain, a non-cash item. The real test is converting the $375 million+ 2026 revenue target into positive cash flow, a path that remains unproven.

The immediate catalyst is the final results call. The company has scheduled its conference call for Wednesday, March 25th at 8:30 a.m. ET. This event is critical for validating the growth plan and addressing investor concerns about the widening EBITDA loss. Management will need to provide a clearer roadmap to profitability to support the stock.

Execution on the new targets and M&A will be the next watchpoints. The raised 2026 guidance of at least $375 million requires hitting $38-40 million in Q1. Any deviation will be scrutinized. Additionally, the company's active M&A strategy, including recent acquisitions, must now demonstrate integration success and margin improvement to justify the capital deployed.